GW

Gareth Willis

Founder and CEO

Exosla Therapeutics

Therapeutic Areas

Exosla Therapeutics Pipeline

DrugIndicationPhase
EV-based Neurorestorative TherapyNeurological injury in newborn infantsPre-clinical